相似文献
1
The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.
J Am Chem Soc. 2010 Feb 3;132(4):1230-1. doi: 10.1021/ja909947a.
2
Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.
Bioorg Med Chem Lett. 2013 Feb 15;23(4):1004-7. doi: 10.1016/j.bmcl.2012.12.037. Epub 2012 Dec 27.
3
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
J Med Chem. 2009 Aug 13;52(15):4623-30. doi: 10.1021/jm900410u.
4
Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.
Bioorg Med Chem Lett. 2012 Mar 1;22(5):1985-8. doi: 10.1016/j.bmcl.2012.01.029. Epub 2012 Jan 24.
5
Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
J Med Chem. 2012 Sep 13;55(17):7759-71. doi: 10.1021/jm3007917. Epub 2012 Sep 5.
6
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127543. doi: 10.1016/j.bmcl.2020.127543. Epub 2020 Sep 12.
7
Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.
J Med Chem. 2014 Dec 26;57(24):10544-50. doi: 10.1021/jm501527z. Epub 2014 Dec 4.
8
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.
Chem Biol. 2008 Jan;15(1):70-7. doi: 10.1016/j.chembiol.2007.12.010.
9
Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
J Med Chem. 2013 May 23;56(10):4028-43. doi: 10.1021/jm400241j. Epub 2013 May 13.
10
Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.
Cell Biochem Biophys. 2021 Mar;79(1):11-24. doi: 10.1007/s12013-020-00950-1. Epub 2020 Oct 15.
引用本文的文献
1
A journey into the regulatory secrets of the purine nucleotide biosynthesis.
Front Pharmacol. 2024 Feb 20;15:1329011. doi: 10.3389/fphar.2024.1329011. eCollection 2024.
2
The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Infections.
ACS Infect Dis. 2021 Nov 12;7(11):3062-3076. doi: 10.1021/acsinfecdis.1c00342. Epub 2021 Sep 30.
3
A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.
J Mol Model. 2021 Jan 9;27(2):35. doi: 10.1007/s00894-020-04663-3.
4
Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.
Cell Biochem Biophys. 2021 Mar;79(1):11-24. doi: 10.1007/s12013-020-00950-1. Epub 2020 Oct 15.
5
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127543. doi: 10.1016/j.bmcl.2020.127543. Epub 2020 Sep 12.
6
Genetic ablation of purine salvage in reveals nucleotide uptake from the host cell.
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21160-21165. doi: 10.1073/pnas.1908239116. Epub 2019 Sep 30.
7
Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.
Medchemcomm. 2019 May 2;10(8):1290-1301. doi: 10.1039/c9md00179d. eCollection 2019 Aug 1.
8
Horizontal transfer of a pathway for coumarate catabolism unexpectedly inhibits purine nucleotide biosynthesis.
Mol Microbiol. 2019 Dec;112(6):1784-1797. doi: 10.1111/mmi.14393. Epub 2019 Oct 1.
9
Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection.
Sci Rep. 2019 Jan 17;9(1):190. doi: 10.1038/s41598-018-37490-x.
10
Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.
J Med Chem. 2018 Jun 14;61(11):4739-4756. doi: 10.1021/acs.jmedchem.7b01839. Epub 2018 May 30.
本文引用的文献
1
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
J Med Chem. 2009 Aug 13;52(15):4623-30. doi: 10.1021/jm900410u.
2
IMP dehydrogenase: structure, mechanism, and inhibition.
Chem Rev. 2009 Jul;109(7):2903-28. doi: 10.1021/cr900021w.
3
A kinetic alignment of orthologous inosine-5'-monophosphate dehydrogenases.
Biochemistry. 2008 Aug 19;47(33):8689-96. doi: 10.1021/bi800674a. Epub 2008 Jul 22.
4
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.
Chem Biol. 2008 Jan;15(1):70-7. doi: 10.1016/j.chembiol.2007.12.010.
5
An updated review on Cryptosporidium and Giardia.
Gastroenterol Clin North Am. 2006 Jun;35(2):291-314, viii. doi: 10.1016/j.gtc.2006.03.006.
6
Cryptosporidium: a water-borne zoonotic parasite.
Vet Parasitol. 2004 Dec 9;126(1-2):37-56. doi: 10.1016/j.vetpar.2004.09.004.
7
The genome of Cryptosporidium hominis.
Nature. 2004 Oct 28;431(7012):1107-12. doi: 10.1038/nature02977.
8
Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
J Biol Chem. 2004 Sep 24;279(39):40320-7. doi: 10.1074/jbc.M407121200. Epub 2004 Jul 21.
9
Complete genome sequence of the apicomplexan, Cryptosporidium parvum.
Science. 2004 Apr 16;304(5669):441-5. doi: 10.1126/science.1094786. Epub 2004 Mar 25.
10
Gene transfer in the evolution of parasite nucleotide biosynthesis.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3154-9. doi: 10.1073/pnas.0304686101. Epub 2004 Feb 18.
Zotero 插件